Life Sciences
Top stories summarized by our editors
12/15/2017

A round of pre-Series A financing led by medical device company Accuron MedTech pulled in $1.9 million for Singapore-based Advent Access, which makes the av-Guardian technology to facilitate vascular access creation for dialysis patients. The company intends to use the proceeds to support its submission for CE mark approval in the European Union within the next 18 months.

Full Story:
MassDevice (Boston)
More Summaries:
European Union
12/15/2017

The IQon Elite Spectral CT scanner, which features the dual-energy NanoPanel prism detector with an yttrium-based scintillator, was launched by Philips. The scanner enables concurrent conventional and spectral CT image generation and separation of various energy X-rays simultaneously emitted by a tube source.

Full Story:
MedGadget
More Summaries:
CT scanner, Philips
12/15/2017

BGI's NIFTY cell-free DNA-based noninvasive prenatal test kit was granted CE mark approval by European regulators. The test, which runs on the BGISEQ-500 sequencing platform and is designed for fetal chromosomal aneuploidies, provides analysis of cell-free DNA from maternal blood at 10 gestation weeks and estimates the fetal risk for trisomy 18, trisomy 21 and trisomy 13.

More Summaries:
BGI
12/15/2017

May 9-10, 2018 | Washington, D.C.
Join us for the 11th year of the Annual FDA/AdvaMed Medical Devices and Diagnostics Statistics Conference. This annual conference brings together leading authorities from FDA, industry and academia to address statistical topics to include real-world evidence, statistical versus clinical significance, multiple data sources reader studies and agreement.

Full Story:
advamed.org
12/15/2017

Women In Bio recruited leading women -- and one man -- in biomedicine to talk about progress, setbacks and prospects for women in the industry for a magazine article. Their complete responses to the questions asked "add insights, examples, and alternatives in thinking about how to accelerate improved conditions and parity for industry women," writes Wayne Koberstein, executive editor of Life Science Leader magazine.

Full Story:
Life Science Leader
More Summaries:
Life Science Leader
12/15/2017

Felicity Muth, a postdoctoral researcher at the University of Nevada, won a $60,000 grant this year from the L'Oreal Foundation for her research on bumblebee cognition and behavior and how neonicotinoids affect foraging and pollinating. Muth will use the funds to hire a research assistant, purchase equipment and collaborate with local organizations to spark local girls' interest in science.

Full Story:
KUNR-FM (Reno, Nev.)
12/15/2017

Alexion will pay $40 million to license Halozyme's Enhanze technology to formulate up to four drugs for subcutaneous injection instead of intravenous infusion, and Halozyme will be eligible to receive up to an additional $160 million for each drug target developed. The deal is one of eight using Enhanze, which "has become the go-to technology for taking IV drugs subcutaneous," said Halozyme President and CEO Helen Torley.

More Summaries:
Alexion, Halozyme, Helen Torley, IV, The deal
12/15/2017

The US Preventive Services Task Force issued updated recommendations discouraging postmenopausal women's use of hormone therapy for the purpose of reducing the risk of heart disease and other chronic ailments, but JoAnn Manson, who holds an endowed chair in women's health at Harvard Medical School, says undertreatment with hormone therapy is the real problem. The American College of Obstetricians and Gynecologists, the North American Menopause Society and the Endocrine Society recommend hormone therapy for women with moderate to severe hot flashes and night sweats, and Manson is among those concerned that clinicians will stop writing prescriptions because of the new guidelines.

Full Story:
Forbes
12/15/2017

OrbiMed General Partner Sven Borho called General Manager Sam Isaly a "true visionary" as Isaly retired from the global biotech investment firm two days after an article in STAT exposed allegations of ongoing sexual harassment and verbal abuse of female staffers. The issue of widespread sexual harassment in biotech and finance came to the fore two years ago after the annual JP Morgan conference, and Endpoints News Editor-in-Chief John Carroll wonders "whether the issue has a noticeable effect on party planning at the upcoming JP Morgan conference."

12/15/2017

The Girl Scouts launched an awareness campaign and is expanding its Think Like a Programmer initiative in elementary schools with the goal of preparing at least 2.5 million girls for careers in science, technology, engineering and mathematics by 2025. The campaign includes a video in which five Girl Scouts play the roles of current and past female STEM icons.

Full Story:
Fast Company online
More Summaries:
Girl Scouts